Elicit
FreemiumAI research assistant for PRISMA-compliant systematic literature reviews
By Tanmay Verma, Founder · Last verified 06 Jul 2026
5.7k views
Added 4/3/2026
95/100Safe BetIn short
Elicit — AI research assistant for PRISMA-compliant systematic literature reviews. Best for Academic researchers conducting PRISMA-compliant systematic reviews, Pharmaceutical R&D teams screening clinical trials, Policy analysts needing citation-grounded evidence summaries. Free to start; paid plans from $49/mo.
Is Elicit actually worth it?
LiveSee what real users actually say. We scan live discussions, reviews and complaints across the web and hand you an honest verdict — in under a minute.
3 free scans · no card needed · downloadable report
Editorial Verdict
Best for
Academic researchers conducting PRISMA-compliant systematic reviewsPharmaceutical R&D teams screening clinical trialsPolicy analysts needing citation-grounded evidence summariesGraduate students writing reproducible literature reviewsMedical device teams evaluating clinical trial data
Not ideal for
Casual users needing quick, non-cited answersTeams needing preprints, patents, or non-English literatureUsers requiring real-time data or news sourcesBudget-conscious users (advanced features start at $49/mo)
If you're doing a formal systematic review, Elicit's benchmarked accuracy (95%+ recall) and PRISMA 2020 compliance make it the only serious choice. Skip it for casual Q&A—it's overkill and expensive.
Skip Elicit if Skip Elicit if you need quick, non-cited answers on general topics or you work outside peer-reviewed academic literature (e.g., preprints, patents, news).
Compare with: Elicit vs Paxton AI, Elicit vs Marvin User Research, Elicit vs Humata AI
Last verified: July 2026
What's new in Elicit
Checked 2 days agoAcross the latest 10 updates: 5 feature updates and 5 community discussions.
FeatureBlog·8 days agoNewest
A more powerful Research Agent, with updated usage limits
Research Agent enhanced with more data sources and higher capacity; Elicit switches from workflow-based to monthly usage pool.
FeatureBlog·May 6
Elicit Systematic Review: Now Built for PRISMA 2020
Systematic review tool updated to support PRISMA 2020 guidelines with full reproducibility and auditability.
FeatureBlog·May 6
Evaluating Elicit’s Systematic Literature Review Capabilities
Elicit achieves 95% search recall, 97% abstract screening, 99% full-text screening, and 96% extraction across 994 Cochrane reviews.
DiscussionBlog·May 4
Planning is unsolved
Discusses limitations of current AI in long-horizon planning tasks like clinical development and launch strategy.
DiscussionBlog·Apr 22
How AI will change Pharma R&D
Based on 500+ conversations with pharma companies, outlines impact of AI on R&D processes.
DiscussionBlog·Apr 10
What’s going on in AI?
Excerpt from April 2026 investor update covering situational awareness and hard-to-verify tasks.
FeatureBlog·Mar 30
Engineering interviews in the era of agents
Updated stance on coding assistants in engineering interviews, reflecting changes since 2024.
FeatureBlog·Mar 3
Introducing the Elicit API
New API allows search of 138M+ papers and generation of Reports programmatically.
DiscussionBlog·Feb 18
The AI Force Multiplier – Orchestrating Integrated Evidence to Drive Biopharma Value
AI enhances RWE planning as a corporate strategic mandate in biopharma.
DiscussionBlog·Jan 19
Science and Culture, Part II: The Arnold-Huxley debate
Examines historical debate on sciences vs humanities in education, part of Elicit's Culture series.
Viability Score
95/100
Safe BetHow likely is Elicit to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
momentum
100
funding runway
80
website health
90
wrapper dependency
100
Last calculated: July 2026
How we score →Key Features
- Semantic search over 138M+ academic papers
- Search 545,000 clinical trials from ClinicalTrials.gov
- PRISMA 2020-compliant systematic review workflow
- Automated abstract screening (97% accuracy)
- Automated full-text screening (99% accuracy)
- Data extraction from up to 20,000 data points per project
- Customizable research reports with up to 80 papers
- Strict Screening criteria for reproducible selection
- Research Agents for competitive landscapes and topic exploration
- Keyword search across Elicit, PubMed, and ClinicalTrials.gov
- Sentence-level citations for all AI-generated claims
- Claude Opus 4.5 integration for reduced hallucinations
- Elicit API for programmatic search and report generation
- Export to RIS, CSV, BIB, PDF, DOCX
- Extract and interpret from figures in research papers (Scale tier)
About Elicit
FreemiumIntermediateAPI availableWeb · API
Elicit is an AI research assistant purpose-built for researchers, scientists, and evidence-driven professionals who need to synthesize scientific literature quickly and reproducibly. It automates systematic review workflows—search, screening, data extraction, and report generation—with sentence-level citations. You search across over 138 million academic papers and 545,000 clinical trials. Elicit's Systematic Review tool now supports PRISMA 2020 guidelines with auditable screening. Benchmarks on 994 Cochrane reviews show 95% search recall, 97% abstract screening accuracy, 99% full-text screening, and 96% extraction accuracy. You can generate customizable reports with up to 80 papers, use Strict Screening criteria for reproducible selection, and leverage Claude Opus 4.5 for reduced hallucinations. The newly launched Elicit API enables programmatic search and report generation. Unlike general-purpose AI, Elicit enforces structured workflows with interactive tables and multi-step processes. It's trusted by over 5 million researchers. Paid tiers start at $49/month (Pro) for systematic review workflows.
Behind the Verdict
Elicit isn't another chat wrapper for science. It's a structured workflow tool that forces reproducibility: every claim cites a sentence, every screening step is auditable. That matters when you're submitting a review to Cochrane or FDA. The May 2026 PRISMA 2020 update and the benchmark on 994 Cochrane reviews give it the most defensible accuracy claims in the space. We'd reach for this when you need to screen thousands of records and extract data at scale—the Scale tier's 9x usage and 40,000-paper capacity are built for that. Where it bites: the free tier is too limited for real work (no systematic review workflow), and the jump from Plus to Pro is steep. Also, Elicit indexes only peer-reviewed papers and clinical trials—no preprints, patents, or news. If your literature review is exploratory or cross-domain, a tool like Consensus (which covers more preprint servers) might be a lighter fit. But for a defensible, PRISMA-compliant systematic review, nothing else comes close.
Researching Elicit? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Elicit actually fits — and what changes day-one when you adopt it.
PhD student conducting a systematic review
You input your PICO research question, and Elicit searches 138M+ papers using semantic search. You apply Strict Screening to select 50 papers, then extract data into 20 custom columns. Finally, you generate a PRISMA flow diagram and a 80-paper report with citations.
Outcome: A complete, reproducible systematic review draft in hours instead of weeks, ready for peer review.
Pharma R&D analyst screening clinical trials
You ask Elicit to find all Phase 3 trials for a specific drug class. It retrieves and screens 1,500+ trials, extracts endpoints and sample sizes, and flags relevant safety data.
Outcome: A structured evidence table mapping competitive landscape, supporting go/no-go decisions.
Use Cases
- Automating systematic literature reviews for meta-analysis
- Extracting sample sizes and effect sizes across dozens of studies
- Building comparison tables of methodologies from competing papers
- Synthesizing contradictory findings across multiple sources
- Staying current with new research via Alerts
- Generating competitive landscape reports for R&D teams
Models Under the Hood
Claude Opus 4.5Proprietary Elicit extraction model
as of 2026-07-06
Limitations
- Extraction quality can suffer with poorly formatted PDFs or scanned documents.
- Limited support for gray literature (preprints, patents) and non-academic sources.
- No citation network or visual mapping features.
- Collaboration requires Scale tier.
- Free tier caps at 2 Automated Reports/month and limited Research Agent access.
as of 2026-07-01
12-month cost
Project the real annual outlay, including the implied monthly cost when only an annual tier is published.
Annual total
Free
Over 12 months
Effective monthly
Free
Billed monthly
Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.
Plans compared
For each published Elicit tier: who it actually fits, and what it adds vs. the previous tier. Cross-reference the cost calculator above for projected annual outlay.
Basic
$0/mo
Ideal for
Casual exploration with minimal needs: a student or individual researcher who wants unlimited search and summaries but no systematic review tools.
What this tier adds
Free entry point: limited Research Agent, 2 reports/month, 2 table columns, no export.
Plus
$7/user/mo (billed $84/yr)
Ideal for
Deeper research beyond basics: researchers needing more daily Research Agent access, exports, and clinical trial search.
What this tier adds
Adds increased Research Agent, 4 reports/month, 5 table columns, export to RIS/CSV/BIB/PDF/DOCX.
Pro (yearly)
$29/user/mo (billed $348/yr)
Pro (monthly)
$49/user/mo
Scale (yearly)
$49/user/mo (billed $588/yr)
Scale (monthly)
$169/user/mo
Enterprise
Custom
Ideal for
Large organizations: pharmaceutical companies, universities, and government agencies needing custom scale, security, and integration.
What this tier adds
Custom: screen 40,000 papers, extract 40 columns, SSO/SAML, 2FA, single-tenancy, unlimited API, custom data sources.
Integrations
Zotero
Where the pricing makes sense
The company stage and team size where Elicit's pricing actually pencils out — and where peers do it cheaper.
Elicit's free tier is generous for basic search and summaries, but systematic review workflows start at $49/mo (Pro), which is steep for individual students. For teams, Scale at $169/mo adds collaboration. Compared to lower-cost tools like Scite ($12/mo) or Papers ($9/mo), Elicit justifies its premium with full PRISMA compliance and benchmarked accuracy. For budget-conscious researchers, the Plus tier at $7/yr offers more reports but no systematic review.
Setup time & first value
How long it actually takes to get something useful out of Elicit — broken out by persona, not the marketing-page minute.
For a PhD student, expect 15 minutes to sign up, learn the interface, and run your first search. Setting up a systematic review with custom columns and screening criteria takes about 30–60 minutes. The Pro tier unlocks the full workflow; free tier can only do basic search and summaries.
Switching to or from Elicit
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
Migrating in
- →From spreadsheets: upload paper lists via RIS/BIB export and use Elicit's column extraction to automate data gathering.
- →From Covidence: export screening decisions from Covidence as RIS and import into Elicit to continue extraction.
Migrating out
- ↗To Covidence: export data from Elicit as CSV or RIS, then import into Covidence for full review collaboration.
- ↗To Zotero: use Zotero integration to sync references and notes out of Elicit.
Resources & Guides
Frequently Asked Questions
Tools that pair well with Elicit
Common stack mates teams adopt alongside Elicit, with the specific reason each pairing earns its keep.
Featured Head-to-Head Comparisons
Alternatives to Elicit
View allUsed Elicit? Help shape our editorial sentiment research.